Khan Sheraz, Batchelor Hannah, Hanson Peter, Perrie Yvonne, Mohammed Afzal R
Aston Pharmacy School, Aston University, Birmingham B4 7ET, UK.
J Pharm Sci. 2011 Oct;100(10):4281-94. doi: 10.1002/jps.22613. Epub 2011 May 10.
Poor water solubility leads to low dissolution rate and consequently, it can limit bioavailability. Solid dispersions, where the drug is dispersed into an inert, hydrophilic polymer matrix can enhance drug dissolution. Solid dispersions were prepared using phenacetin and phenylbutazone as model drugs with polyethylene glycol (PEG) 8000 (carrier), by melt fusion method. Phenacetin and phenylbutazone displayed an increase in the dissolution rate when formulated as solid dispersions as compared with their physical mixture and drug alone counterparts. Characterisation of the solid dispersions was performed using differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM). DSC studies revealed that drugs were present in the amorphous form within the solid dispersions. FTIR spectra for the solid dispersions of drugs suggested that there was a lack of interaction between PEG 8000 and the drug. However, the physical mixture of phenacetin with PEG 8000 indicated the formation of hydrogen bond between phenacetin and the carrier. Permeability of phenacetin and phenylbutazone was higher for solid dispersions as compared with that of drug alone across Caco-2 cell monolayers. Permeability studies have shown that both phenacetin and phenylbutazone, and their solid dispersions can be categorised as well-absorbed compounds.
水溶性差会导致溶出速率低,进而可能限制生物利用度。在固体分散体中,药物分散于惰性亲水性聚合物基质中可提高药物溶出度。以非那西丁和保泰松为模型药物,聚乙二醇(PEG)8000为载体,采用熔融法制备固体分散体。与物理混合物和单独的药物相比,非那西丁和保泰松制成固体分散体时溶出速率增加。采用差示扫描量热法(DSC)、傅里叶变换红外光谱法(FTIR)和扫描电子显微镜(SEM)对固体分散体进行表征。DSC研究表明,药物在固体分散体中以无定形形式存在。药物固体分散体的FTIR光谱表明,PEG 8000与药物之间缺乏相互作用。然而,非那西丁与PEG 8000的物理混合物表明非那西丁与载体之间形成了氢键。与单独的药物相比,非那西丁和保泰松固体分散体在Caco-2细胞单层上的渗透性更高。渗透性研究表明,非那西丁和保泰松及其固体分散体均可归类为吸收良好的化合物。